{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:09:17Z","timestamp":1792019357970,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3564,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National High Technology Research and Development Program of China","award":["2006AA090304"],"award-info":[{"award-number":["2006AA090304"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30772588, 30721005"],"award-info":[{"award-number":["30772588, 30721005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1093\/annonc\/mdp335","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T01:44:23Z","timestamp":1253670263000},"page":"597-607","source":"Crossref","is-referenced-by-count":48,"title":["Echinoside A, a new marine-derived anticancer saponin, targets topoisomerase2\u03b1 by unique interference with its DNA binding and catalytic cycle"],"prefix":"10.1016","volume":"21","author":[{"given":"M.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.-H.","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-P.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-H.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdp335_bb0010","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/np040031y","article-title":"Marine natural products and related compounds in clinical and advanced preclinical trials","volume":"67","author":"Newman","year":"2004","journal-title":"J Nat Prod"},{"key":"10.1093\/annonc\/mdp335_bb0015","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/1381612013397113","article-title":"Intercalators as anticancer drugs","volume":"7","author":"Brana","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1093\/annonc\/mdp335_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev.bi.58.070189.002031","article-title":"DNA topoisomerase poisons as antitumor drugs","volume":"58","author":"Liu","year":"1989","journal-title":"Annu Rev Biochem"},{"key":"10.1093\/annonc\/mdp335_bb0025","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1073\/pnas.0704002104","article-title":"Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies","volume":"104","author":"Azarova","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/annonc\/mdp335_bb0030","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdp335_bb0035","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1158\/1078-0432.CCR-06-1277","article-title":"Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo","volume":"13","author":"Huang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdp335_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1056-8719(00)00088-5","article-title":"A fast and sensitive technique to study the kinetics and the concentration dependencies of DNA fragmentation during drug-induced apoptosis","volume":"43","author":"Steinfelder","year":"2000","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1093\/annonc\/mdp335_bb0045","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.cad.0000132238.23050.f5","article-title":"Anticancer activity of methoxymorpholinyl doxorubicin (PNU 152243) on human hepatocellular carcinoma","volume":"15","author":"Yuan","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1093\/annonc\/mdp335_bb0050","first-page":"4903","article-title":"Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives","volume":"51","author":"Tanabe","year":"1991","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdp335_bb0055","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1158\/1535-7163.MCT-07-0147","article-title":"Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain","volume":"6","author":"Qin","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1093\/annonc\/mdp335_bb0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0006-2952(01)00732-8","article-title":"Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes","volume":"62","author":"Meng","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1093\/annonc\/mdp335_bb0065","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1021\/bi00388a018","article-title":"Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active form","volume":"26","author":"Osheroff","year":"1987","journal-title":"Biochemistry"},{"key":"10.1093\/annonc\/mdp335_bb0070","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1158\/0008-5472.CAN-07-0938","article-title":"Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance","volume":"67","author":"Antony","year":"2007","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdp335_bb0075","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1021\/bi00163a015","article-title":"Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives","volume":"31","author":"Yamashita","year":"1992","journal-title":"Biochemistry"},{"key":"10.1093\/annonc\/mdp335_bb0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0006-2952(99)00382-2","article-title":"F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action","volume":"59","author":"Perrin","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1093\/annonc\/mdp335_bb0085","doi-asserted-by":"crossref","first-page":"17643","DOI":"10.1074\/jbc.273.28.17643","article-title":"Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage","volume":"273","author":"Fortune","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdp335_bb0090","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1158\/0008-5472.CAN-05-0707","article-title":"Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors","volume":"65","author":"Jensen","year":"2005","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdp335_bb0095","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1124\/mol.106.027714","article-title":"Salvicine functions as novel topoisomerase II poison by binding to ATP pocket","volume":"70","author":"Hu","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1093\/annonc\/mdp335_bb0100","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature06396","article-title":"Structural basis for gate-DNA recognition and bending by type IIA topoisomerases","volume":"450","author":"Dong","year":"2007","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdp335_bb0105","author":"Accelrys","year":"2000"},{"key":"10.1093\/annonc\/mdp335_bb0110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1164\/rccm.200404-447OC","article-title":"Association of vitamin D receptor gene polymorphisms with childhood and adult asthma","volume":"170","author":"Raby","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/annonc\/mdp335_bb0115","author":"Tripos","year":"2001"},{"key":"10.1093\/annonc\/mdp335_bb0120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp Cell Res"},{"key":"10.1093\/annonc\/mdp335_bb0125","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/mol.105.011544","article-title":"Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase","volume":"68","author":"Lu","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1093\/annonc\/mdp335_bb0130","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters","volume":"446","author":"Higgins","year":"2007","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdp335_bb0135","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1158\/1078-0432.CCR-06-2154","article-title":"Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo","volume":"13","author":"Xiao","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdp335_bb0140","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bcp.2005.12.001","article-title":"Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice","volume":"71","author":"Wang","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1093\/annonc\/mdp335_bb0145","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1093\/nar\/16.9.3907","article-title":"DNA unwinding and inhibition of T4 DNA ligase by anthracyclines","volume":"16","author":"Montecucco","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1093\/annonc\/mdp335_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0079-6603(00)64006-0","article-title":"Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice","volume":"64","author":"Fortune","year":"2000","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1093\/annonc\/mdp335_bb0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/1568026033452519","article-title":"Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes","volume":"3","author":"Wilstermann","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"10.1093\/annonc\/mdp335_bb0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/np068054v","article-title":"Natural products as sources of new drugs over the last 25 years","volume":"70","author":"Newman","year":"2007","journal-title":"J Nat Prod"},{"key":"10.1093\/annonc\/mdp335_bb0165","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2174\/138161207782360555","article-title":"Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison","volume":"13","author":"Le Tourneau","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1093\/annonc\/mdp335_bb0170","first-page":"4085","article-title":"Psammaplin A, a natural phenolic compound, has inhibitory effect on human topoisomerase II and is cytotoxic to cancer cells","volume":"19","author":"Kim","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1093\/annonc\/mdp335_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2007.08.098","article-title":"A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells","volume":"108","author":"Ahn","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdp335_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-7258(03)00058-5","article-title":"Catalytic topoisomerase II inhibitors in cancer therapy","volume":"99","author":"Larsen","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1093\/annonc\/mdp335_bb0185","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1021\/jm000017s","article-title":"Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening","volume":"43","author":"Boehm","year":"2000","journal-title":"J Med Chem"},{"key":"10.1093\/annonc\/mdp335_bb0190","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1021\/bi00065a016","article-title":"Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II","volume":"32","author":"Robinson","year":"1993","journal-title":"Biochemistry"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419382985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419382985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/3\/597\/395424\/mdp335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:14:18Z","timestamp":1624518858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419382985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0923753419382985"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdp335","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}